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PURPOSE: Across the lifespan, physical activity levels decrease and time spent sedentary 27 
typically increases. However, little is known about the impact that these behavioural changes 28 
have on skeletal muscle mass regulation. The primary aim of this study was to use a step 29 
reduction model to determine the impact of reduced physical activity and increased sedentary 30 
time on daily myofibrillar protein synthesis rates in healthy young men. METHODS: Eleven 31 
men (22±2 y) completed 7 days of habitual physical activity (HPA) followed by 7 days of 32 
step reduction (SR). Myofibrillar protein synthesis rates were determined during HPA and SR 33 
using the deuterated water (
2
H2O) method combined with the collection of skeletal muscle 34 
biopsies and daily saliva samples. Gene expression of selected proteins related to muscle 35 
mass regulation and oxidative metabolism were determined via real time RT-qPCR. 36 
RESULTS: Daily step count was reduced by approximately 91% during SR (from 37 
13054±2763 to 1192±330 steps·d
-1
; P<0.001) and this led to an increased contribution of 38 
sedentary time to daily activity (73±6 to 90±3%; P<0.001). Daily myofibrillar protein 39 
synthesis decreased by approximately 27% from 1.39±0.32 %·d
-1
 during HPA to 1.01±0.38 40 
%·d
-1
 during SR (P<0.05). MAFbx and myostatin mRNA expression were up-regulated 41 
whereas mTOR, p53 and PDK4 mRNA expression were down-regulated following SR 42 
(P<0.05). CONCLUSION: One week of reduced physical activity and increased sedentary 43 
time substantially lowers daily myofibrillar protein synthesis rates in healthy young men.  44 








Skeletal muscle mass, physical function and metabolic health progressively decline with 51 
advancing age. This could be attributed to the gradual reduction in levels of physical activity 52 
and/or the increase in sedentary behaviour that typically occurs across the lifespan (1). The 53 
importance of physical activity in maintaining skeletal muscle mass and function is well 54 
appreciated and recent evidence has implicated sedentariness, distinct from physical activity, 55 
as a risk factor for age-related loss of skeletal muscle mass and strength (2). However, the 56 
physiological processes which may contribute to the negative consequences of physical 57 
inactivity and sedentary behaviour on skeletal muscle mass and function are relatively 58 
unknown.    59 
Skeletal muscle mass is governed by overall protein balance, which is determined by rates of 60 
muscle protein synthesis and breakdown. Any loss of muscle mass must be explained by an 61 
overall negative protein balance (i.e., muscle protein breakdown must exceed muscle protein 62 
synthesis). Extreme muscle disuse (i.e., bed rest or limb immobilization), where voluntary 63 
muscular contractile activity is essentially removed, results in substantial loss of skeletal 64 
muscle mass (3, 4). This is associated with reductions in postabsorptive muscle protein 65 
synthesis rates and the development of ‘anabolic resistance’; that is, a reduced stimulation of 66 
postprandial muscle protein synthesis (3). On the other hand, the impact of disuse on muscle 67 
protein breakdown rates in humans is poorly defined. Whilst disuse models provide 68 
invaluable information on the impact of severe muscle unloading, their extreme nature may 69 
not accurately reflect typical physically inactive and sedentary lifestyles (5).  70 
Step reduction has been proposed as a model to more accurately examine the underlying 71 
physiology of physically inactive and sedentary individuals and also explore the 72 
physiological changes that occur when inactivity is enforced by injury, illness and/or other 73 
 
 
significant life events (5-7). Step reduction has been shown to reduce insulin sensitivity (8, 74 
9), but few studies have evaluated its impact on skeletal muscle mass regulation. Breen and 75 
colleagues reported reduced postprandial myofibrillar protein synthesis rates following 14 76 
days of step reduction in older, overweight individuals (10). These findings are supported by 77 
more recent data showing reduced integrated myofibrillar protein synthesis rates throughout a 78 
two-week period of step reduction in older, overweight adults (11).  79 
While these findings are important, there are currently no data available on muscle protein 80 
synthesis rates over shorter periods of time typically associated with recovery from injury 81 
and/or acute illness (i.e., ≤ one week). The above studies also describe responses in older, 82 
overweight individuals, but young and older individuals have distinct responses to muscle 83 
disuse (12, 13). The influence of step reduction on skeletal muscle mass regulation in young 84 
individuals has yet to be studied but is important to characterize to enhance our understanding 85 
of the impact of reduced physical activity and increased sedentary behaviour on skeletal 86 
muscle mass regulation at various stages across the lifespan.  87 
Accordingly, the primary purpose of the present study was to use the step reduction model to 88 
determine the impact of short-term reduced physical activity and increased sedentary time on 89 
myofibrillar protein synthesis rates in healthy young men. The deuterated water (
2
H2O) 90 
approach was used as it allows myofibrillar protein synthesis rates to be measured under free-91 
living conditions over time frames where quantifiable changes in muscle mass are unlikely to 92 
occur, providing important insight into longer-term muscle mass regulation (14-16). It was 93 
hypothesized that one week of reduced physical activity and increased sedentary time would 94 
reduce daily myofibrillar protein synthesis rates.  95 
METHODS 96 
Participants and ethical approval  97 
 
 
Eleven healthy young men participated in the present study which took place between June 98 
2016 and February 2018. All participants were recreationally active and self-reported 99 
engaging in structured physical activity ≥ 3 times/week for > 6 months prior to inclusion. 100 
Five of the participants reported undertaking only aerobic-based exercise, four of the 101 
participants reported undertaking only resistance-based exercise and two of the participants 102 
reported undertaking both aerobic and resistance-based exercise. None of the participants 103 
were competitive endurance and/or power athletes. The participants’ baseline characteristics 104 
are presented in Table 1. Prior to providing informed written consent, each volunteer was 105 
informed of the experimental procedures and potential risks associated with the experimental 106 
intervention. Participants were screened prior to inclusion in the study and deemed healthy 107 
based on their responses to a general health questionnaire. Exclusion criteria included being a 108 
current or recent (last 6 months) smoker, hypertensive (≥ 140/90 mmHg), diagnosed with 109 
diabetes and/or suffering from a recent injury. Participants deemed eligible were 110 
subsequently fitted with an ActivPAL3
TM
 accelerometer (see Accelerometry section below) 111 
for 7 days to objectively assess daily step count. Any individual completing <7000 steps·d
-1 112 
was excluded from participating in the study. The study was approved by the National 113 
Research Ethics Service Committee West Midlands, Edgbaston, United Kingdom (Reference: 114 
16/WM/0011) and conformed to standards for the use of human participants in research as 115 
outlined in the Declaration of Helsinki. The intervention was registered at clinicaltrials.gov 116 
prior to data collection (Identifier: NCT02624011). 117 
Study overview 118 
An overview of the study is presented in Figure 1. Following an initial 
2
H2O dosing day (day 119 
-2) and one maintenance day (see 
2
H2O dosing protocol section below), participants 120 
completed 7 days of habitual physical activity (HPA) followed by 7 days of step reduction 121 
(SR). For the first 7 days, participants were instructed to maintain their habitual physical 122 
 
 
activity levels (i.e., regular ambulation and structured physical activity). During SR, 123 
participants were instructed to reduce their step count to ~1500 steps·d
-1
, be as sedentary as 124 
possible and refrain from any form of structured physical activity for the remaining 7 days. A 125 
target daily step count of ~1500 steps·d
-1 
was set during SR as large-scale global data suggest 126 
that the average daily step count for adults is <5000 steps·d
-1
 (17). An ActivPAL3
TM
 127 
accelerometer (see Accelerometry section below) was worn throughout HPA and SR to 128 
objectively assess physical activity levels and sedentary time. As the ActivPAL3
TM
 129 
accelerometer does not provide visual feedback on daily step count, participants were also 130 
provided with a pedometer during the SR period to help prevent their daily step count 131 
exceeding the 1500 steps·d
-1 
threshold. A member of the investigative team was on call 132 
throughout the SR period to help participants with activities of daily living (e.g., food 133 
shopping) that were not practical within the step count parameters set out. Weighed 4-day 134 
food diaries were completed during HPA and SR (see Dietary intake section below). Muscle 135 
biopsies were collected on days 0, 7 and 14, saliva samples were collected daily and an oral 136 
glucose tolerance test (OGTT) was conducted on days 7 and 14.  137 
Experimental visits 138 
On the morning of day 0, participants arrived at the laboratory at 08:00 in a fasted state from 139 
22:00 the evening before. After voiding, participants were weighed in light clothing to the 140 
nearest 0.1 kg (OHaus, Champ II scales, USA) and height measured to the nearest centimetre 141 
(Stadiometer, Seca, UK). Body composition (whole-body fat-free mass and body fat 142 
percentage) was subsequently determined by dual-energy X-ray absorptiometry (DXA, 143 
Discovery QDR W series; Hologic). Following the DXA scan, a saliva sample (see 
2
H2O 144 
dosing protocol section below) was obtained before collection of a muscle biopsy from the 145 
vastus lateralis muscle. Muscle biopsies were collected using the Bergström needle technique 146 
with manual suction under local anaesthesia (1% lidocaine). Muscle biopsy samples were 147 
 
 
blotted and any visible fat, blood or connective tissue removed before snap freezing in liquid 148 
nitrogen and storing at -80°C for later analysis. Subsequent muscle biopsies (days 7 and 14) 149 
were taken from separate incisions in an alternating pattern between legs. Participants then 150 




H2O dosing protocol section below) 151 
before being fitted with an ActivPAL3
TM 
accelerometer prior to leaving the laboratory.  152 
Following 7 days of HPA, participants returned to the laboratory at 08:00 on day 7, again in a 153 
fasted state from 22:00 the evening before. Participants were weighed prior to insertion of a 154 
20G cannula into an antecubital vein to allow for repeated blood sampling during the OGTT. 155 
A saliva sample was subsequently obtained before collection of the second muscle biopsy. 156 
Following the muscle biopsy, a baseline blood sample was then drawn before participants 157 
completed an OGTT. Participants consumed 75 g dextrose as a 25% solution with subsequent 158 
blood samples drawn at 30, 60, 90 and 120 minutes to assess postprandial blood glucose, 159 
insulin and non-esterified fatty acid (NEFA) concentration responses. Blood samples were 160 
collected into EDTA-containing Vacutainers (BD, New Jersey, USA) prior to centrifugation 161 
at 1500 g for 15 minutes at 4°C. Aliquots containing plasma were stored at -80°C. 162 
Participants remained in a semi-supine position throughout the OGTT and once completed, 163 
consumed a single maintenance bolus of 
2
H2O before leaving the laboratory. Following 7 164 
days of SR, participants arrived at 08:00 in a fasted state for the final laboratory visit (i.e., 165 
day 14) which was identical to the experimental protocol completed on day 7.  166 
2
H2O dosing protocol 167 
The 
2
H2O dosing protocol consisted of one dosing day and 16 maintenance days (14). On day 168 
-2, participants completed a 
2
H2O loading day. Following collection of a background saliva 169 
sample, participants were provided with 8 x 50 mL boluses of 70% 
2
H2O (Cambridge Isotope 170 
Laboratories, Massachusetts, USA) to increase deuterium (
2
H) enrichment in body water to 171 
 
 
0.5-1%. Approximately 60-90 minutes was allowed between each bolus to negate side effects 172 
(e.g., vertigo, nausea) previously reported upon consumption of large volumes of 
2
H2O over 173 
short periods of time. The 
2
H2O protocol was well tolerated with none of the participants 174 
reporting any adverse effects. For each subsequent day, participants were provided with a 175 
daily 50 mL maintenance bolus of 
2
H2O to consume. Participants were instructed to consume 176 
the daily bolus upon waking up to ensure consistency and minimize the risk of missed doses. 177 
The time at which each bolus was consumed was recorded and participants were instructed to 178 
bring the empty bottles back in on each laboratory visit to measure compliance. All boluses 179 
were returned void, suggesting full compliance with the 
2
H2O protocol.   180 
To measure 
2
H enrichment in body water, saliva samples were collected daily. Participants 181 
lightly chewed a cotton swab until completely saturated with saliva (~2-3 minutes). On days -182 
2, 0, 7 and 14, swabs were collected in the laboratory, immediately placed in a 5 mL syringe 183 
and the saliva compressed into sample tubes and stored at -80°C for later analysis. On the 184 
remaining days when participants were not in the laboratory, daily saliva samples were 185 
collected at home and stored in pre-labelled falcon tubes in the fridge until the next 186 
laboratory visit where samples were stored as described above. Participants were instructed to 187 
provide their saliva sample at least 2 hours following their last 
2
H2O bolus and at least 30 188 
minutes after their last meal or drink and to record the time at which the sample was 189 
collected.  190 
Accelerometry 191 
During the screening process, participants were fitted with an ActivPAL3
TM
 accelerometer 192 
(PAL Technologies Ltd., Glasgow, UK) to assess daily step count. Participants were also 193 
fitted with an ActivPAL3
TM
 accelerometer during HPA and SR to objectively assess physical 194 
activity levels and sedentary time. The ActivPAL3
TM
 accelerometer was attached to the 195 
 
 
anterior of the upper thigh using waterproof dressing. Participants were required to wear the 196 
accelerometer at all times except when bathing. Complete 14-day accelerometry data were 197 
obtained from all 11 participants over the experimental intervention. During the 7-day period 198 
of SR, participants were also provided with a hip-worn pedometer (Yamax Digi-Walker SW-199 
200) which provided visual feedback on their step count to aid compliance with the 1500 200 
steps·d
-1 
requirement. Daily step count from the hip-worn pedometer was recorded by 201 
participants before bed. Accelerometry data were downloaded from devices using 202 
ActivPAL3
TM
 analysis software (PAL Technologies Ltd., Glasgow, UK, v7.2.32).  203 
Dietary intake 204 
The evening prior to each experimental visit on days 0, 7 and 14, participants received the 205 
same standardized meal (~689 kcal, providing ~55 energy% (En%) carbohydrate, ~20 En% 206 
protein, and ~25 En% fat). A weighed 4-day food diary was completed over the first 7-day 207 
period of HPA and over the second 7-day period of SR to evaluate energy and macronutrient 208 
intake. Participants were required to include two week-days and both weekend days in their 209 
recordings. Dietary records were analysed using Dietplan software (Forestfield Software Ltd., 210 
v6.70.67). 211 
Plasma analyses 212 
Plasma glucose (Glucose Oxidase kit, Instrumentation Laboratories, Cheshire, UK) and 213 
NEFA (NEFA kit, Randox, London, UK) concentrations were analysed in duplicate using 214 
enzymatic colorimetric assays using an ILAB 650 Clinical Chemistry Analyser 215 
(Instrumentation Laboratory, Warrington, UK). Plasma insulin concentrations were 216 
determined in duplicate using commercially available enzyme-linked immunosorbent assay 217 





H enrichment  219 
Body water 
2
H enrichment was analysed from daily saliva samples collected throughout the 220 
study as previously described (14). Briefly, samples were centrifuged at 10000 g and then 221 
diluted 70-fold with ddH2O. Subsequently, small plastic cups holding 4 mg of catalyst (5 % 222 
platinum on alumina, 325 mesh, Sigma-Aldrich, St. Louis, USA) were placed inside 3 mL 223 
glass vials (Labco Exetainer, Labco limited, Lampeter, UK) and 300 uL of diluted saliva was 224 
then added. Air in each vial was simultaneously evacuated and replaced by hydrogen gas. 225 
Once prepared, the vials were left at 21 °C for 24 hours for 
2
H equilibration to occur between 226 
the hydrogen gas and the saliva samples. The 
2
H enrichment of the hydrogen gas was then 227 
measured in duplicate on a GC-C-IRMS (Micromass 205 Optima IRMS fitted with a 228 
Multiprep and Gilson autoinjector, Micromass UK Limited, 206 Manchester, UK). Standard 229 
regression curves were applied to assess the linearity of the mass spectrometer and to account 230 
for 
2
H loss during equilibration. 231 
Myofibrillar bound 
2
H-alanine enrichment 232 
For measurement of 
2
H-alanine enrichment in the myofibrillar fractions, ~50 mg wet muscle 233 
tissue was hand-homogenized on ice using a pestle in a standard extraction buffer (10 μL·mg
-234 
1
). The samples were then spun at 2500 g for 5 minutes at 4ºC. The pellet was washed with 235 
500 μL of ddH2O and centrifuged at 250 g for 10 minutes at 4ºC. The myofibrillar protein 236 
was solubilized by adding 1 mL of 0.3 M NaOH and heating at 50ºC for 30 minutes with 237 
vortex mixing every 10 minutes. Samples were centrifuged at 9500 g for 5 minutes at 4ºC, 238 
the supernatant containing the myofibrillar proteins was collected and the collagen pellet was 239 
discarded. Myofibrillar proteins were precipitated by the addition of 1 mL of 1 M PCA and 240 
spinning at 700 g for 10 minutes at 4 ºC. The myofibrillar protein was washed twice with 241 
70% ethanol and hydrolysed overnight in 2 mL of 6 M HCL at 110˚C. The free amino acids 242 
 
 
from the hydrolysed myofibrillar protein pellet were dried under a nitrogen stream while 243 
being heated to 120 ºC. The free amino acids were then dissolved in 25% acetic acid solution, 244 
passed over cation exchange AG 50W-X8 resin columns (mesh size: 100-200, ionic form: 245 
hydrogen; Bio-Rad Laboratories, Hercules, CA), and eluted with 2 M NH4OH. Thereafter, 246 
the eluate was dried, and the purified amino acids were derivatized to their N(O,S)-247 
ethoxycarbonyl ethyl esters. The derivatized samples were measured using a gas 248 
chromatography-isotope ratio mass spectrometer (GC-IRMS) (Thermo Fisher Scientific, 249 
MAT 253; Bremen, Germany) equipped with a pyrolysis oven and a 60 m DB-17MS column 250 
(no. 122-4762; Agilent, Wilmington, DE, USA) and 5 m precolumn. Ion masses 2 and 3 were 251 




H ratios of myofibrillar protein bound alanine. A series of 252 
known standards were applied to assess linearity of the mass spectrometer and to control for 253 
the loss of tracer. 254 
Gene expression analysis 255 
Total RNA was isolated from ~20 mg of frozen powdered muscle tissue by homogenising in 256 
1 mL of TRI Reagent (Sigma Aldrich, Gillingham, UK) using an IKA T10 basic ULTRA-257 
TURRAX homogenizer (IKA, Oxford, UK). To achieve phase separation, 200 μL of 258 
chloroform was added to each sample followed by vigorous shaking for 15 seconds, 15 259 
minutes at ambient temperature and subsequent centrifugation at 12000 g for 15 minutes at 260 
4°C. The RNA-containing supernatant was then removed and mixed with an equal volume of 261 
2-propanol. RNA was purified on Reliaprep spin columns (Promega, Madison, Wisconsin, 262 
USA) using the manufacturer’s instructions, which includes a DNase treatment step. A 263 
FLUOstar Omega microplate reader (LVis function) was used to determine the RNA 264 
concentration and purity of each sample. The ratio of absorbance at 260 nm and 280 nm was 265 
≥ 2.0 for all samples. 900 ng of total RNA was reverse-transcribed to cDNA in 20 μL 266 
volumes using the nanoScript 2 RT kit and a combination of oligo(dT) and random primers 267 
 
 
(Primerdesign, Southampton, UK) as per the manufacturer’s instructions. The resultant 268 
cDNA was diluted to 10 ng/mL prior to RT-qPCR analysis. All analysis was performed in 269 
triplicate using Primerdesign custom designed primers (Supplementary Table 1) or 270 
commercially available 18S, GAPDH, TOP1, B2M and ACTB (Primerdesign Southampton, 271 
UK) and Precision plus qPCR Mastermix with low ROX and SYBR (Primerdesign 272 
Southampton, UK) on a QuantStudio3 Real-Time PCR System (Applied Biosystems, Thermo 273 
Fisher, UK). Dependent on the gene of interest, 10-50 ng of cDNA was added to each well in 274 
a 20 uL reaction volume. Thermal cycling conditions were 2 minutes at 95°C and 40 cycles 275 
of 10 seconds at 95°C and 60 seconds at 60°C. A post qPCR run melt curve (Applied 276 
Biosystems, Thermo Fisher, UK) was used to ascertain the specificity of each primer. qPCR 277 
results were analysed using Experiment Manager (Thermo Fisher). mRNA expression values 278 
are expressed as fold change relative to the average baseline (i.e., HPA) ∆CQ value using the 279 
2
-∆∆CQ 
method (18). To control for RNA input, the geometric mean of the CQ values for 280 
TOP1, B2M and ACTB was used as an internal control as these were found to be the three 281 
most stable genes across all samples using RefFinder (RefFinder, RRID:SCR_000472) (19). 282 
All gene expression data are presented for n=10 as insufficient muscle tissue was available 283 
for RNA isolation for one participant. Statistical analysis was performed on the 2
-∆∆CQ
 284 
transformed data.  285 
Calculations 286 
Total area under the curve (AUC) for plasma glucose and insulin concentrations was 287 
calculated using the trapezoidal method. The Matsuda index, an index of whole-body insulin 288 
sensitivity, was calculated as previously described (20). Myofibrillar protein fractional 289 
synthetic rate (FSR) was determined using the incorporation of 
2
H-alanine into myofibrillar 290 
protein and the mean 
2
H enrichment in body water between sequential biopsies, corrected by 291 
 
 
a factor of 3.7, as the surrogate precursor based upon 
2
H labelling during de novo alanine 292 
synthesis (14, 15). The standard precursor-product method was used to calculate FSR: 293 
𝐹𝑆𝑅 (% ∙ 𝑑𝑎𝑦−1) = (
𝐸𝑚2 − 𝐸𝑚1
𝐸𝑝𝑟𝑒𝑐𝑢𝑟𝑠𝑜𝑟  × 𝑡
) × 100 
where Em1 and Em2 are the myofibrillar protein-bound 
2
H-alanine enrichments between 294 
sequential muscle biopsies. Eprecursor represents the mean body water 
2
H enrichment between 295 
sequential biopsies corrected by a factor of 3.7 based upon the 
2
H labelling of alanine during 296 
de novo synthesis (14). t represents the time between sequential biopsies in days. 297 
Statistics 298 
Based on previous research (15), sample size calculations showed that n=9 would be 299 
sufficient to detect a difference in daily myofibrillar protein synthesis rates between HPA and 300 
SR conditions using a two-tailed paired samples t-test (95% power, α-level of 0.05, G*power 301 
version 3.1.9.2). Allowing for a 20% dropout rate, eleven participants were recruited. All 302 
statistical analyses were performed using SPSS 22.0 (SPSS, RRID:SCR_002865, Chicago, 303 
IL, USA). Differences between conditions (HPA vs. SR) for accelerometry, dietary intake, 304 
plasma insulin and glucose AUC, Matsuda index, myofibrillar protein FSR and gene 305 
expression were compared using paired sample t-tests. Body water 
2
H enrichment was 306 
analysed using a one-factor repeated measures ANOVA with time as the within-subjects 307 
factor. A two-factor repeated measures ANOVA (condition x time) with condition (HPA vs. 308 
SR) and time (0, 30, 60, 90 and 120 minutes) as within-subjects factors was performed for 309 
analysis of plasma glucose, insulin and NEFA concentrations. Bonferroni post-hoc tests were 310 
conducted to correct for multiple comparisons when a significant condition x time interaction 311 





Daily step count was reduced by approximately 91% during SR (13054±2763 to 1192±330 315 
steps·d
-1
; P<0.001). Self-reported pedometer-derived daily step count during SR (1312±297 316 
steps·d
-1
) was highly correlated with accelerometer-derived daily step count (r = 0.851; 317 
P=0.001). The percentage of total time spent sedentary (73±6 to 90±3%; P<0.001) increased 318 
and percentage of total time spent standing (17±6 to 8±3%; P<0.001) and ambulatory 319 
(10.0±1.0 to 1.0±0.5%; P<0.001) decreased during SR. The number of daily transitions from 320 
a sitting to standing position was also significantly reduced during SR (46±8 to 31±10; 321 
P<0.001).  322 
Body weight and dietary intake 323 
Body weight was not different following HPA and SR (75.3±11.0 to 75.1±10.8 kg; P>0.05).  324 
Dietary intake during HPA and SR is presented in Table 2. Daily energy intake tended to 325 
decrease (P=0.07) whereas both daily protein intake (P<0.01) and protein intake relative to 326 
body weight (P<0.01) significantly decreased during SR. However, absolute carbohydrate 327 
and fat intake and the relative contribution of protein, carbohydrate and fat to overall energy 328 
intake were unchanged across the intervention (P>0.05).   329 
Oral glucose tolerance 330 
Following SR, fasting plasma glucose concentrations were unaltered (P>0.05; Figure 2A), 331 
whereas fasting plasma insulin concentrations increased (P<0.05; Figure 2C). In response to 332 
the OGTT, a significant main effect for time (P<0.001) was observed, with plasma glucose 333 
concentrations elevated at 30 minutes compared to all other time points (P<0.01), at 60 334 
minutes compared to baseline and 120 minutes (P<0.05), and at 90 minutes compared to 120 335 





was not significantly altered by 7 days of SR (P>0.05; Figure 2B). In contrast, a significant 337 
condition x time interaction (P<0.01) was observed for plasma insulin, with greater plasma 338 
insulin concentrations at 60, 90 and 120 minutes of the OGTT following 7 days of SR 339 
(P<0.05; Figure 2C). In line with these findings, plasma insulin AUC (4590±1817 to 340 
6287±1363 µIU·120 min·mL
-1
) was significantly greater following SR (P<0.01; Figure 2D), 341 
corresponding with a decrease in the Matsuda index (6.5±1.8 to 4.5±0.7) (P<0.01; Figure 342 
2F). A significant main effect for time (P<.001) was also observed for plasma NEFA 343 
concentrations, with baseline values being significantly higher at baseline compared to all 344 
other time points (P<0.05), at 30 minutes compared to 60, 90 and 120 minutes (P<0.001) and 345 
at 60 minutes compared to 90 minutes (P<0.05; Figure 2E).  346 
Body water 
2
H enrichment 347 
Figure 3A presents the mean body water 
2
H enrichment on a day-by-day basis. Following the 348 
loading phase on day -2 and a single maintenance day on day -1, body water 
2
H enrichment 349 
reached 0.54±0.09% (day 0). Body water 
2
H enrichment did not change significantly over the 350 
duration of the study with an average body water 
2
H enrichment of 0.59±0.12% during HPA 351 
and 0.64±0.17% during SR (P>0.05).  352 
Myofibrillar protein synthesis 353 
As shown in Figure 3B, daily myofibrillar protein synthesis rates decreased by 354 
approximately 27% from 1.39±0.32 %·d
-1
 during HPA to 1.01±0.38 %·d
-1
 during SR 355 
(P<0.05). 356 
Gene expression 357 
The skeletal muscle mRNA expression of genes implicated in muscle mass regulation and 358 
oxidative metabolism is presented in Figure 4. In relation to the regulation of muscle protein 359 
 
 
synthesis, myostatin mRNA expression was increased following SR and this was paralleled 360 
by reduced mTOR mRNA expression (both P<0.05; Figures 4C and 4D). However, p70S6K 361 
mRNA expression was unchanged following SR (P>0.05; Figure 4E). In regards to muscle 362 
protein breakdown, MuRF1 mRNA expression was unchanged (P>0.05; Figure 4A), whereas 363 
MAFbx mRNA expression was up-regulated following SR (P<0.05; Figure 4B). p53 and 364 
PDK4 mRNA expression both decreased following SR (both P<0.05; Figures 4F and 4G) 365 
with no change in PGC-1α mRNA expression (P>0.05; Figure 4H).  366 
DISCUSSION 367 
The major novel finding of the present study was that one week of reduced physical activity 368 
and increased sedentary time led to a substantial (~27%) decline in daily myofibrillar protein 369 
synthesis rates. This decline in myofibrillar protein synthesis was associated with increased 370 
skeletal muscle mRNA expression of myostatin and MAFbx and decreased mRNA 371 
expression of mTOR. The present findings also show that one week of reduced physical 372 
activity and increased sedentary time led to a decline in whole-body insulin sensitivity, in 373 
addition to decreasing skeletal muscle mRNA expression of selected genes related to 374 
oxidative metabolism (i.e., PDK4 and p53). Together, these findings provide direct evidence 375 
that reduced physical activity and increased sedentary time alters the physiological processes 376 
which regulate skeletal muscle in healthy young individuals.  377 
Across the lifespan, physical activity levels generally decrease and time spent sedentary 378 
typically increases (1). Likewise, injury, illness and/or other significant life events often 379 
necessitate short periods (typically 2-7 days) of reduced physical activity and increased 380 
sedentariness (6, 7). The findings of the present study demonstrate for the first time that just 381 
one week of reduced physical activity and increased sedentary time leads to significant 382 
(~27%) declines in daily myofibrillar protein synthesis rates in young healthy individuals 383 
 
 
(Figure 3B). These findings extend previous observations of reduced postprandial and 384 
integrated myofibrillar protein synthesis rates following two weeks of step reduction in older, 385 
overweight adults (10, 11) and highlights the central role that day-to-day muscular contractile 386 
activity plays in regulating muscle protein synthesis rates. Promotion of regular physical 387 
activity and minimising sedentariness throughout the lifespan should be considered as 388 
integral to the maintenance of skeletal muscle health. 389 
The findings of McGlory and colleagues are most comparable as they also applied 
2
H2O to 390 
measure daily myofibrillar protein synthesis rates (11). The ~27% decline in daily 391 
myofibrillar protein synthesis observed in the present study is substantially greater than the 392 
~12% decline in integrated myofibrillar protein synthesis rates observed by McGlory and 393 
colleagues (11). This may be related to the greater relative change in daily step count induced 394 
by this step reduction intervention (~91%) compared to McGlory et al. (~70%) (11). 395 
Alternatively, this discrepancy could be explained by the duration of step reduction or 396 
differences in the populations studied (i.e., younger vs. older adults). For example, some, but 397 
not all, human muscle disuse studies have shown that 5-14 days of limb immobilization 398 
results in greater loss of muscle mass in younger individuals when compared to older 399 
individuals (12, 21). Thus, it could be hypothesized that a similar pattern of response is seen 400 
from the perspective of muscle protein synthesis, whereby younger individuals are more 401 
susceptible to changes in physical activity status than older individuals. In this regard, an 402 
older comparator group to directly assess age-related differences in the present study would 403 
have been informative and is an important avenue for future research.  404 
A number of factors including habitual physical activity (10), diet composition (22), energy 405 
balance (23) and sleep (24) can influence day-to-day muscle protein synthesis rates. It is also 406 
well established that dietary protein/amino acid administration robustly stimulates muscle 407 
protein synthesis (25-27). Whilst dietary protein intake decreased from habitual levels during 408 
 
 
SR, it is important to note that participants were still consuming 133±13 g·d-1 of dietary 409 
protein during the SR period (Table 2). When expressed relative to body weight, this equates 410 




. This intake is well above the established 411 
recommended dietary allowance for protein of 0.8 g·kg
-1 
of body weight and is also greater 412 
than recently proposed changes to those recommendations (i.e., 1.2-1.6 g·kg
-1 
of body 413 
weight) (28). Energy balance can also influence muscle protein synthesis rates, with studies 414 
showing that energy restriction reduces myofibrillar protein synthesis rates in young and 415 
older individuals (23, 29, 30). In the present study, daily energy intake tended (P=0.07) to 416 
decrease during SR but body weight remained stable, suggesting that participants were not in 417 
negative energy balance. Whilst it is unlikely that modifications in dietary protein and/or 418 
energy intake contributed to the decline in daily myofibrillar protein synthesis rates during 419 
one week of SR, these factors and other dietary related variables (e.g., protein distribution 420 
across the day) cannot be completely ruled out and thus future studies should investigate the 421 
independent and combined impact of these variables on muscle mass regulation.  422 
Previous studies that employed stable isotope infusion protocols within a laboratory setting 423 
provide some insight into what could explain the reduction in daily myofibrillar protein 424 
synthesis rates observed herein. For example, the reduction in regular muscular contractile 425 
activity undoubtedly contributed given that physical activity acts synergistically to enhance 426 
the muscle protein synthetic response to dietary protein/amino acids (24, 31, 32). In addition, 427 
two weeks of step reduction has previously been shown to induce the development of 428 
‘anabolic resistance’ in older adults and thus it is possible that a similar phenomenon was 429 
captured in the long-term measurement of myofibrillar protein synthesis rates in the present 430 
study (10).  431 
The precise acute metabolic mechanisms underpinning the step reduction-induced decline in 432 
myofibrillar protein synthesis rates remain to be confirmed in a younger population. 433 
 
 
Nonetheless, in the present study, a coordinated up-regulation of myostatin expression and 434 
down-regulation of mTOR expression was observed in skeletal muscle following one week of 435 
SR (Figures 4C and 4D). These findings are relatively consistent with previous studies that 436 
have observed increased myostatin expression following human muscle disuse (33, 34). 437 
Myostatin negatively regulates muscle mass in part via inhibition of the mechanistic target of 438 
rapamycin (mTOR), a key regulator of muscle protein synthesis (35). Heightened mRNA 439 
expression of myostatin in conjunction with lowered mRNA expression of mTOR is therefore 440 
entirely consistent with the observed reduction in myofibrillar protein synthesis rates. 441 
To gain further insight into the impact of short-term reduced physical activity and increased 442 
sedentary time on muscle mass regulation, the gene expression of putative markers of muscle 443 
protein breakdown was also determined. Muscle-specific E3 ubiquitin ligases (e.g., muscle 444 
atrophy F-box (MAFbx) and muscle RING finger 1 (MuRF1)) selectively target muscle 445 
proteins for degradation via the 26S proteasome (36). In the present study, an increase in 446 
MAFbx expression was observed whereas MuRF1 expression remained unchanged (Figures 447 
4A and 4B). The disparity in the responsiveness of the E3 ubiquitin ligases to step reduction 448 
is intriguing but has been reported previously following bed rest and limb immobilization in 449 
humans (13, 34). It is possible that the observed decrease in myofibrillar protein synthesis 450 
rates was matched by a similar decrease in muscle protein breakdown, reflecting a reduced 451 
muscle protein turnover, although the increase in MAFbx expression following step reduction 452 
does not support this notion. However, this observation represents a single time point and 453 
may not necessarily reflect dynamic changes that occurred throughout the entire step 454 
reduction period. Clearly further research is required to provide greater insight into the 455 
relative importance of muscle protein breakdown in the context of reduced physical activity 456 
and increased sedentary time.   457 
 
 
In line with previous findings, one week of reduced physical activity and increased sedentary 458 
time led to a decline in whole-body insulin sensitivity (Figure 2). The increased plasma 459 
insulin response (Figures 2C and 2D), without a significant change in the plasma glucose 460 
response to the OGTT (Figure 2A and 2B), supports previous findings in young individuals 461 
(37) and likely represents a compensatory mechanism in order to maintain glycaemic control. 462 
This is in contrast to longer-term (2 weeks) step reduction, where both plasma glucose and 463 
insulin concentrations appear to be elevated in response to an OGTT (11). 464 
The absence of muscle mass measures following step reduction may be considered a 465 
limitation of the present investigation. However, recent evidence has shown that myofibrillar 466 
protein synthesis rates measured using 
2
H2O are predictive of long-term changes in skeletal 467 
muscle mass (38). Thus, it is possible that the observed decline in daily myofibrillar protein 468 
synthesis would contribute to loss of muscle mass with chronic reduced physical activity and 469 
increased sedentary time. It should also be noted that structured physical activity was reduced 470 
and sedentary time was increased in the present study, precluding any conclusions being 471 
made on the independent impact of either of these distinct behaviours. However, given that a 472 
large proportion of the global population are both physically inactive and highly sedentary 473 
(1), the present findings are highly relevant. Finally, physical activity levels tend to be lower 474 
in women compared to men and thus future research utilising a similar study design in 475 
women is warranted (17).   476 
In conclusion, one week of step reduction lowers daily myofibrillar protein synthesis rates 477 
and alters the expression of several genes within skeletal muscle related to muscle mass 478 
regulation and oxidative metabolism in healthy young men. Promotion of regular physical 479 
activity and minimising sedentariness throughout the lifespan should be considered as 480 
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Table 1. Participant characteristics at baseline 664 
Variable Value 
Age (y) 22.2 ± 2.2 
Height (m) 1.77 ± 0.08 
Body mass (kg) 74.0 ± 11.0 
BMI (kg·m-2) 23.4 ± 2.4 
Body fat (%) 18.6 ± 3.2 
Whole body FFM (kg) 60.0 ± 7.2 
Leg FFM (kg) 20.2 ± 2.4 
Values are mean±SD. n=11. BMI, body mass index; FFM, fat-free mass.  665 
 666 
 667 
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Table 2. Dietary intake during habitual physical activity (HPA) and step reduction (SR) 669 
Variable HPA SR 
Energy intake (kcal·d-1)  2625 ± 732 2380 ± 864 
Protein (g·kg-1·d-1) 2.1 ± 0.7 1.8 ± 0.6* 
Protein intake (g·d-1) 156 ± 51 133 ± 45* 
Carbohydrate intake (g·d-1) 297 ± 142 279 ± 165 
Fat intake (g·d-1) 83 ± 34  77 ± 33  
Protein (En%) 26 ± 13 24 ± 12 
Carbohydrate (En%) 46 ± 13 46 ± 12  
Fat (En%) 28 ± 9 29 ± 10  
Values are mean±SD. n=11. *(P<0.01) indicates a significant difference between HPA and SR 670 














FIGURE HEADINGS 683 
Figure 1. Study overview. 684 
Figure 2. Plasma metabolite responses to an oral glucose tolerance test (OGTT) following 7 685 
days of habitual physical activity (HPA) and 7 days of step reduction (SR) in young males 686 
(n=11). Data are mean±SD. A two-factor repeated measures ANOVA was performed for 687 
analysis of plasma glucose (A), insulin (C) and NEFA (E) responses to the OGTT. Plasma 688 
glucose (B) and insulin (D) area under the curve (AUC) and Matsuda index (F) were 689 
analysed using paired sample t-tests. A: significant main effect for time (P<0.001), *P<0.01 690 
compared to all other time points, †P<0.05 compared to 0 and 120 minutes, ‡P<0.05 691 
compared to 120 minutes. B: no significant effect. C: significant condition x time interaction 692 
(P<0.01), *P<0.05 compared with corresponding HPA value. D: *P<0.01 compared with 693 
HPA. E: significant main effect for time (P<0.001), *P<0.05 compared to all other time 694 
points, †P<0.001 compared to 60, 90 and 120 minutes, ‡P<0.05 compared to 90 minutes. F: 695 
*P<0.01 compared with corresponding HPA value. 696 
Figure 3. Body water 
2
H enrichment and daily myofibrillar protein fractional synthesis rates 697 
(FSR) during 7 days of habitual physical activity (HPA) and 7 days of step reduction (SR) in 698 
young males (n=11). Data are mean±SD. Body water 
2
H enrichment (A) was analysed using 699 
a one-factor repeated measures ANOVA. Myofibrillar protein FSR (B) was analysed using a 700 
paired sample t-test. Body water 
2
H enrichment remained in steady state for the duration of 701 
the study (P>0.05). *(P<0.05) indicates a significant difference between HPA and SR 702 
conditions. 703 
Figure 4. Skeletal muscle mRNA expression of muscle RING finger 1 (MuRF1; A) muscle 704 
atrophy F-box (MAFbx; B), myostatin (C), the mechanistic target of rapamycin (mTOR; D), 705 
ribosomal protein S6 kinase beta-1 (p70S6K; E), p53 (F), pyruvate dehydrogenase kinase 4 706 
 
 
(PDK4; G) and peroxisome proliferator activated receptor gamma coactivator 1-alpha (PGC-707 
1α; H) following 7 days of habitual physical activity (HPA) and 7 days of step reduction (SR) 708 
in young males (n=10). Data are mean±SD. Data were analysed using paired sample t-tests. 709 
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Supplementary Table 1. RT-qPCR primer sequences 742 
Gene Forward primer Reverse primer 
MuRF1 5’-GACGCCCTGAGAGCCATT-3’ 5’-CCTCTTCCTGATCTTCTTCTTCAAT-3’ 
MAFbx 5’-AACTCAAATACAAAATAGGACGCTTT-3’ 5’-CCTTCGCCTTCTCAAAACAAAC-3’ 
Myostatin 5’-GTCGAGACTCCTACAACAGTG-3’ 5’-TCCAGTATACCTTGTACCGTCTT-3’ 
mTOR 5’-CTGATGCTGGACCGTCTGA-3’ 5’-TCTTGTTAGTCTAAATGGAATCTTCTC-3’ 
p70S6K 5’-GCAAGCTGGACAAACTATCACA-3’ 5’-CCACTGAGATAATACTTGTGCTATAATG-3’ 
p53 5’-GTGGAGTATTTGGATGACAGAAAC-3’ 5’-GTAGTTGTAGTGGATGGTGGTAC-3’ 
PDK4 5’-GAGGGACACTCAGGACACTTTAC-3’ 5’-TGGAGGAAACAAGGGTTCACAC-3’ 
PGC-1α 5’-TTGCTAAACGACTCCGAGAAC-3’ 5’-GACCCAAACATCATACCCCAAT-3’ 
MuRF1, muscle RING finger 1; MAFbx, muscle atrophy F-box; mTOR, the mechanistic target of rapamycin; 743 
p70S6K, ribosomal protein S6 kinase beta-1; PDK4, pyruvate dehydrogenase kinase 4; PGC-1α, peroxisome 744 
proliferator activated receptor gamma coactivator 1-alpha.  745 
